This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Accelrys Receives Highest Rating In Gartner's Latest Laboratory Informatics System Report

SAN DIEGO, Oct. 8, 2013 /PRNewswire/ --  Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced that Gartner, Inc­., the leading provider of research and analysis on the global information technology industry, has rated the company "very high" in a recent report[1] on Electronic Laboratory Notebook (ELN) vendors. Accelrys was the only vendor to achieve the highest possible rating of "very high" in all five categories of new product development (NPD) – concept, research, development, transfer and manufacturing – and was among only four ELN vendors of 23 to also offer a Laboratory Information Management System (LIMS) solution.


The report is based on insights collected by Gartner throughout hundreds of interviews, briefings and interactions with various clients.

According to Gartner research director Michael Shanler, "Leaders with ERP and product life cycle management (PLM) experience are asking how difficult it is to move toward developing end-to-end scientific insights to better support the entire spectrum from earlier-stage concept development through late-stage manufacturing. This allure of end-to-end informatics is very attractive, but entering this space requires IT organizations to rethink their approach towards laboratory-centric activities."

"Accelrys software solutions cover the entire product lifecycle for organizations that rely on science to innovate in their products and processes," said Accelrys President and CEO Max Carnecchia. "We believe Accelrys' very high ratings in Gartner's recent report confirm our industry-leading ability to advance predictive, sustainable innovation across the industries we serve."

Access the full Gartner report: Product Innovation Requires Laboratory Informatics Systems to Transcend Phases.

About Accelrys, Inc.

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,812.19 +19.51 0.11%
S&P 500 2,089.14 +2.55 0.12%
NASDAQ 5,102.8080 +0.33 0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs